Table 2 Comparison of complications, treatment, and clinical outcomes.
All (n = 130) | ACE-I/ARB (n = 30) | No ACE-I/ARB (n = 100) | P value | |
|---|---|---|---|---|
Length of hospital stay, days | 23.8 ± 16.5 | 20.3 ± 14.3 | 24.9 ± 17.1 | 0.189 |
Treatment, n (%) | ||||
Antibiotics | 99 (76.2) | 26 (86.7) | 73 (73.0) | 0.123 |
Lopinavir/ritonavir | 73 (56.2) | 20 (66.7) | 53 (53.0) | 0.186 |
Darunavir/cobicistat | 33 (25.4) | 8 (26.7) | 25 (25.0) | 0.854 |
Hydroxychloroquine | 91 (70.0) | 24 (80.0) | 67 (67.0) | 0.173 |
Glucocorticoid | 48 (36.9) | 13 (44.8) | 35 (35.0) | 0.374 |
IVIG | 13 (10.0) | 2 (6.7) | 11 (11.0) | 0.731 |
Oxygen therapy | 87 (66.9) | 21 (70.0) | 66 (66.0) | 0.683 |
Invasive MV | 25 (19.2) | 7 (23.3) | 18.0 (18.0) | 0.516 |
ECMO | 4 (3.1) | 2 (6.7) | 2 (2.0) | 0.231 |
CRRT | 9 (6.9) | 4 (13.3) | 5 (5.0) | 0.210 |
ICU admission | 38 (29.2) | 10 (33.3) | 28 (28.0) | 0.595 |
Complications, n (%) | ||||
ARDS | 34 (26.2) | 14 (46.7) | 20 (20.0) | 0.004 |
Acute kidney injury | 25 (19.2) | 11 (36.7) | 14 (14.0) | 0.006 |
Shock | 54 (41.5) | 15 (50.0) | 39 (39.0) | 0.284 |
Clinical outcomes, n (%) | 0.008 | |||
In-hospital death | 36 (27.7) | 14 (46.7) | 22 (22.0) | |
Recovery | 94 (72.3) | 16 (53.3) | 78 (78.0) | |
